These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24644536)

  • 1. What nephrolopathologists need to know about antiphospholipid syndrome-associated nephropathy: Is it time for formulating a classification for renal morphologic lesions?
    Mubarak M; Nasri H
    J Nephropathol; 2014 Jan; 3(1):4-8. PubMed ID: 24644536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catastrophic antiphospholipid syndrome: a clinical review.
    Nayer A; Ortega LM
    J Nephropathol; 2014 Jan; 3(1):9-17. PubMed ID: 24644537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal involvement in antiphospholipid syndrome.
    de Azevedo FVA; Maia DG; de Carvalho JF; Rodrigues CEM
    Rheumatol Int; 2018 Oct; 38(10):1777-1789. PubMed ID: 29730854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic lupus erythematosus and antiphospholipid syndrome - diagnostic and therapeutic problems].
    Zdrojewski Z
    Wiad Lek; 2018; 71(1 pt 1):40-46. PubMed ID: 29558350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus.
    Daugas E; Nochy D; Huong DLT; Duhaut P; Beaufils H; Caudwell V; Bariety J; Piette JC; Hill G
    J Am Soc Nephrol; 2002 Jan; 13(1):42-52. PubMed ID: 11752020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicomorphological features of nephropathy in primary and secondary antiphospholipid syndrome].
    Kozlovskaia NL; Shilov EM; Meteleva NA; Varshavskiĭ VA; Kushnir VV; Shakhnova EA; Miroshnichenko NG; Serova AG; Nesterova SG
    Ter Arkh; 2007; 79(6):16-25. PubMed ID: 17684961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracapillary proliferation in IgA nephropathy; recent findings and new ideas.
    Nasri H; Mubarak M
    J Nephropathol; 2015 Jan; 4(1):1-5. PubMed ID: 25657978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid antibodies and renal involvement.
    Gigante A; Gasperini ML; Cianci R; Barbano B; Giannakakis K; Di Donato D; Fuiano G; Amoroso A
    Am J Nephrol; 2009; 30(5):405-12. PubMed ID: 19713697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid Syndrome Nephropathy: From Pathogenesis to Treatment.
    Tektonidou MG
    Front Immunol; 2018; 9():1181. PubMed ID: 29904380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of antiphospholipid syndrome nephropathy (APSN) in patients with systemic lupus erythematosus (SLE).
    Miranda JM; Jara LJ; Calleja C; Saavedra MA; Bustamante RM; Angeles U
    Reumatol Clin; 2009; 5(5):209-13. PubMed ID: 21794612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical manifestations of APS-nephropathy in primary antiphospholipid syndrome].
    Shilov EM; Kozlovskaia NL; Meteleva NA; Kozlovskaia LV; Varshavskiĭ VA; Miroshnichenko NG; Blokhina GV; Serova AG; Nesterova SG; Smolianitskiĭ AIa
    Ter Arkh; 2003; 75(6):22-7. PubMed ID: 12920954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of renal manifestations of ANCA-associated vasculitis.
    Galesic K; Ljubanovic D; Horvatic I
    J Nephropathol; 2013 Jan; 2(1):6-19. PubMed ID: 24475421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal Involvement in Antiphospholipid Syndrome.
    Turrent-Carriles A; Herrera-Félix JP; Amigo MC
    Front Immunol; 2018; 9():1008. PubMed ID: 29867982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy.
    Rahimi Z
    J Nephropathol; 2012 Oct; 1(3):143-51. PubMed ID: 24475405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and treatment of APS renal involvement.
    Tektonidou MG
    Lupus; 2014 Oct; 23(12):1276-8. PubMed ID: 25228725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two Faces of the Same Coin: A Case Report of Antiphospholipid Syndrome Nephropathy.
    de Melo Marques SH; Ferreira HAN; de Morais Nunes ATP; Silva RNP; Norton SMMS
    Eur J Case Rep Intern Med; 2017; 4(3):000542. PubMed ID: 30755930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid Syndrome and the Kidney.
    Sciascia S; Baldovino S; Schreiber K; Solfietti L; Roccatello D
    Semin Nephrol; 2015 Sep; 35(5):478-86. PubMed ID: 26573550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgM nephropathy; can we still ignore it.
    Vanikar A
    J Nephropathol; 2013 Apr; 2(2):98-103. PubMed ID: 24475434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies.
    Cheunsuchon B; Rungkaew P; Chawanasuntorapoj R; Pattaragarn A; Parichatikanond P
    Nephrology (Carlton); 2007 Oct; 12(5):474-80. PubMed ID: 17803471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.